Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Oncology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Oncology Other
    Annual Report Finds Declines in Cancer Incidence and Death in US, But Wide Variation in Lung Cancer Trends - (DGNews)
    Clinical Guidelines Issued on the Diagnosis, Management of Metastatic Spinal Cord Compression - (DGNews)
    Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients: A Meta-analysis - (JAMA)
    Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial - (JAMA)
    Folic Acid, B Vitamins Have No Effect on Cancer Risk in Women at High Risk of CVD - (DGNews)

    News archive

     Recent webcasts/CME - Oncology Other

    Webcasts/CME archive

     Recent cases - Oncology Other
      Experience with Adjuvant Chemotherapy for Pseudomyxoma Peritonei Secondary to Mucinous Adenocarcinoma of the Appendix with Oxaliplatin / Fluorouracil /Leucovorin (FOLFOX4)
      Transsacral Colon Fistula : Late Complication after Resection, Irradiation and Free Flap Transfer of Sacral Chondrosarcoma
      Metastatic Colorectal Cancer to a Primary Thyroid Cancer
      Inflammatory Myofibroblastic Tumor of Epididymis: A Case Report and Review of Literature
      Intravascular Leiomyosarcoma of the Brachiocephalic Region - Report of an Unusual Tumour Localisation: Case Report And Review of the Literature

      Cases archive
        




      my personal edition > oncology other > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Interstitial Brachytherapy Can Salvage Vaginal Recurrences of Endometrial Cancer: Presented at ESTRO

      By Adrian Burton
      Special to DG News

      PRAGUE, CZECH REPUBLIC -- September 19, 2002 -- American researchers have found that interstitial brachytherapy can achieve complete control of vaginal recurrences of endometrial cancer.

      Currently there are limited therapeutic options for patients who have a recurrence of endometrial cancer in the vaginal wall -- major surgery has many side effects, external beam radiation is associated with limited survival, and external beam plus intracavity radiation has resulted in limited success.

      Normal intracavity irradiation might deliver incomplete doses because of tumour position, explained Dr. Subir Nag, a professor of radiology at Ohio State University, in Columbus, Ohio, speaking here today at the 21st annual meeting of the European Society for Therapeutic and Radiation Oncology (ESTRO). "Usually these types of tumour are situated at the top of the vaginal cavity where it is difficult to deliver a full dose with normal intracavity methods."

      With the new technique, he added, "what we have done is to put needles directly into the tumour, and therefore deliver a full dose of radiation right where it is needed. By doing so we give a much higher dose to the tumour itself, but less to the vaginal mucosa."

      Between September 1989 and September 2000, Dr. Nag's team enrolled 13 previously unirradiated patients (mean age 70 years) with vaginal recurrences of endometrial adenocarcinoma and treated them by brachytherapy. The small number of patients enrolled in the study is owed to the fact that this is not a common type of cancer, he explained.

      Eleven patients received a total of 45-50 Gy pelvic external radiation plus a mean boost of 28.3 Gy (range 18 - 35 Gy) by brachytherapy. The remaining two patients received only brachytherapy (40 or 50 Gy). Brachytherapy was delivered using a modified perineal Syed template loaded with either 192Ir (n=12) or 137Cs (n=1). After suturing into place, the brachytherapy source was left for two days. Mean tumour size was 2.2 cm (range 1.5 - 6 cm); 10 were situated at the vaginal apex, three on the vaginal wall.

      Although three patients relapsed with metastases at distant points, all patients showed complete local control at five years. At eight years, disease specific survival was 77 percent.

      "Local control of 100 percent is very unusual," explained Dr. Nag, "especially at five years. And if we take into account that survival rate at eight years was 77 percent, we are almost talking about curative therapy. With this system we also see less damage caused to the bladder and rectum. Technically, this treatment is more difficult [to perform] than standard intracavity treatment, but if people learn how to do it we might see much better results for this problem," Dr. Nag concluded.



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send